2-Iminobiotin

DRUG2 trials

Sponsors

Neurophyxia B.V., Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions

Cardiac ArrestHypoxic Ischemic Brain InjuryPerinatal Asphyxia

Phase 1

TIBOHCA: Safety, Tolerability and Pharmacokinetics of 2-Iminobiotin (2-IB) After OHCA

TerminatedNCT02836340

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Cardiac Arrest, Hypoxic Ischemic Brain Injury

Start: 2016-05-31End: 2020-04-30Updated: 2021-02-18

Phase 2

A Study of 2-Iminobiotin in Neonates With Perinatal Asphyxia

TerminatedNCT01626924

Neurophyxia B.V.Perinatal Asphyxia

Start: 2012-06-30End: 2016-03-31Updated: 2017-05-25

Related Papers

Rationale and methods of the Antioxidant and NMDA receptor blocker Weans Anoxic brain damage of KorEa OHCA patients (AWAKE) trial.

2022-07-234 citations